Ion Beam Applications SA IBA (GB:0GZK) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ion Beam Applications SA (IBA) showcased robust growth in its third quarter of 2024, with a significant increase in equipment order intake reaching EUR 215 million and a strong order book valued at EUR 1.4 billion. The company also highlighted a successful EUR 93 million funding round for its joint venture, PanTera, to advance the production of actinium 225, alongside notable progress in its Proton Therapy and Other Accelerators businesses. With a positive financial outlook and strategic investments, IBA remains confident in its performance for the year.
For further insights into GB:0GZK stock, check out TipRanks’ Stock Analysis page.